维维股份(600300) - 2024 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2024 was CNY 1,108,717,337.53, representing a year-on-year increase of 0.83%[4] - Net profit attributable to shareholders reached CNY 126,686,116.53, a significant increase of 251.48% compared to the same period last year[4] - The basic earnings per share (EPS) was CNY 0.08, reflecting a 300.00% increase year-on-year[4] - The weighted average return on equity rose by 2.76 percentage points to 3.93%[4] - The company's net profit margin improved, with operating profit showing a positive trend due to lower financial expenses, which decreased from ¥7,009,393.75 in Q1 2023 to ¥2,302,259.03 in Q1 2024[17] - The net profit for Q1 2024 was CNY 125,977,782.61, a significant increase from CNY 35,116,658.03 in Q1 2023, representing a growth of approximately 259%[18] - The total comprehensive income attributable to the parent company was CNY 126,686,116.53, compared to CNY 36,043,577.16 in the previous year, marking an increase of approximately 251%[19] Cash Flow and Liquidity - The net cash flow from operating activities was negative at CNY -206,489,307.51, a decline of 693.40% compared to the previous year[4] - The cash flow from operating activities showed a net outflow of CNY -206,489,307.51, contrasting with a positive cash flow of CNY 34,797,561.46 in Q1 2023[21] - The cash and cash equivalents at the end of Q1 2024 were CNY 520,400,472.00, down from CNY 531,434,057.69 at the end of Q1 2023[22] - The company incurred total operating expenses of CNY 1,513,273,285.16 in Q1 2024, compared to CNY 1,240,453,858.28 in Q1 2023, reflecting an increase of about 22%[21] - The investment activities generated a net cash inflow of CNY 109,592,602.05, significantly higher than CNY 11,965,516.21 in Q1 2023[22] - In Q1 2024, the net cash flow from financing activities was -$81,403,328.93, compared to -$64,287,510.56 in the previous year, indicating a significant increase in cash outflow[33] - The total cash and cash equivalents at the end of Q1 2024 were $451,253,456.94, down from $590,255,547.62 at the beginning of the period, reflecting a net decrease of $139,002,090.68[33] Assets and Liabilities - Total assets at the end of the reporting period were CNY 4,389,311,513.72, down 1.72% from the end of the previous year[4] - The total liabilities decreased to ¥1,040,599,180.51 from ¥1,243,192,707.97, reflecting a reduction of about 16.3%[14] - The company's total assets decreased to ¥4,389,311,513.72 from ¥4,465,927,258.57, a decline of approximately 1.7%[14] - The retained earnings increased to ¥1,381,332,226.86 from ¥1,254,646,110.32, showing a growth of about 10.1%[14] - The company's liabilities decreased from CNY 1,500,000,000.00 at the end of 2023 to CNY 1,450,000,000.00 as of March 31, 2024, showing a reduction in financial obligations[24] - The total assets increased to CNY 4,530,673,171.63 in Q1 2024 from CNY 4,460,779,589.34 in Q1 2023[27] - The total liabilities rose to CNY 1,879,503,190.32 in Q1 2024, compared to CNY 1,854,333,574.34 in Q1 2023[27] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 65,803[7] - The largest shareholder, Xuzhou Xinseng Investment Holding Group Co., Ltd., holds 30.91% of the shares[8] Operational Insights - The company did not report any significant new product developments or market expansion strategies during this quarter[10] - The company plans to focus on market expansion and new product development in the upcoming quarters[28] Inventory and Costs - Inventory increased significantly to ¥841,608,336.40 as of March 31, 2024, up from ¥699,618,958.71 at the end of 2023, indicating a rise of approximately 20.2%[12] - Total operating costs decreased to ¥1,055,194,886.64 in Q1 2024 from ¥1,062,334,493.31 in Q1 2023, reflecting a reduction of approximately 0.7%[17] - The company reported a decrease in short-term borrowings from ¥134,984,280.00 to ¥99,984,280.00, a reduction of approximately 26%[14] - Long-term investments remained stable, with long-term equity investments at ¥41,486,581.04, a marginal increase from ¥41,445,722.49[13] - Research and development expenses decreased to CNY 1,155,768.18 in Q1 2024 from CNY 1,990,262.96 in Q1 2023, a reduction of approximately 42%[28] - The company reported a decrease in financial expenses to CNY 783,612.41 in Q1 2024 from CNY 6,406,106.92 in Q1 2023, a decline of about 87%[28]